The effect of cholinergic and other pharmacologic agents on brain monophosphoinositide turnover in vivo.
D000109:Acetylcholine / Q000378:metabolism*; D000661:Amphetamine / Q000494:pharmacology; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001626:Bethanechol Compounds / Q000494:pharmacology; D001921:Brain / Q000378:metabolism*; D002845:Chromatography; D002854:Chromatography, Paper; D010277:Parasympathomimetics / Q000494:pharmacology*; D010278:Parathion / Q000494:pharmacology*; D010424:Pentobarbital / Q000494:pharmacology; D010743:Phospholipids / Q000378:metabolism*; D010862:Pilocarpine / Q000494:pharmacology; D051381:Rats; D014316:Tritium
D001626:Bethanechol Compounds; D010277:Parasympathomimetics; D010743:Phospholipids; D010862:Pilocarpine; D014316:Tritium; D010278:Parathion; D001285:Atropine; D000661:Amphetamine; D010424:Pentobarbital; D000109:Acetylcholine